Abstract 3577: A first assessment of CD8-PET/CT with 89Zr-Crefmirlimab as predictive biomarker for response to standard of care immunotherapy in patients with solid tumors

Authors: Guillaume Potdevin, Isabelle Ayx, Laura Dillon, Emilie Mahieu, Hadassah Sade, Günter Schmidt

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-3577

Source: Full article